MET and neoplasm: MET-IHC (SP44 Ventana Medical System, Roche) was used to detect MET overexpression, which was defined as a staining intensity of 2+ or 3+ (≥10% of tumor cells with membrane or cytoplasmic staining of moderate or strong intensity).